Timothy C. Stonesifer net worth and biography

Timothy Stonesifer Biography and Net Worth

Director of Insulet

Timothy Stonesifer has served on our Board of Directors since January 2024. He has been the Chief Financial Officer at Alcon Inc. since April 2019. Prior to joining Alcon, he served as Executive Vice President and Chief Financial Officer at Hewlett Packard Enterprise from November 2015 through September 2018. Prior to that role, Mr. Stonesifer acted as Senior Vice President and Chief Financial Officer, Enterprise Group at HP Co. since 2014. Before joining HP Co., he served as Chief Financial Officer of General Motors’ International Operations from 2011 to 2014. Previously, he served as Chief Financial Officer of Alegco Scotsman, a storage company, from 2010 to May 2011; Chief Financial Officer of Sabic Innovative Plastics (formerly GE Plastics) from 2007 to 2010; and various other positions at General Electric since joining the company in 1989. Mr. Stonesifer holds a Bachelor of Arts in Economics from the University of Michigan.

What is Timothy C. Stonesifer's net worth?: The estimated net worth of Timothy C. Stonesifer is at least $1.32 million as of June 3rd, 2026. Mr. Stonesifer owns 9,041 shares of Insulet stock worth more than $1,323,693 as of June 5th. This net worth estimate does not reflect any other investments that Mr. Stonesifer may own. Learn More about Timothy C. Stonesifer's net worth.
How do I contact Timothy C. Stonesifer?: The corporate mailing address for Mr. Stonesifer and other Insulet executives is 100 NAGOG PARK, ACTON MA, 01720. Insulet can also be reached via phone at (978) 600-7000 and via email at [email protected]. Learn More on Timothy C. Stonesifer's contact information.
Has Timothy C. Stonesifer been buying or selling shares of Insulet?: Within the last three months, Timothy C. Stonesifer has bought $400,392.90 in shares of Insulet stock. Most recently, on Wednesday, June 3rd, Timothy C. Stonesifer bought 2,790 shares of Insulet stock. The stock was acquired at an average cost of $143.51 per share, with a total value of $400,392.90. Following the completion of the transaction, the director now directly owns 9,041 shares of the company's stock, valued at $1,297,473.91. Learn More on Timothy C. Stonesifer's trading history.
Who are Insulet's active insiders?: Insulet's insider roster includes Charles Alpuche (COO), Eric Benjamin (SVP), Luciana Borio (Director), Lauren Budden (Group Vice President, CAO and Controller), Bret Christensen (EVP), Laetitia Cousin (SVP), Sally Crawford (Director), John Fallon (Director), Mark Field (SVP and Chief Technology Officer), Wayne Frederick (Director), James Hollingshead (CEO), John Kapples (Senior Vice President and General Counsel), Dan Manea (SVP), Wayde McMillan (CFO), Michael Minogue (Director), Shacey Petrovic (CEO), Timothy Scannell (Director), Prem Singh (SVP), Michael Spears (SVP), and Timothy Stonesifer (Director). Learn More on Insulet's active insiders.
Are insiders buying or selling shares of Insulet?: In the last twelve months, Insulet insiders bought shares 2 times. They purchased a total of 4,820 shares worth more than $900,239.80. In the last twelve months, insiders at the medical instruments supplier sold shares 2 times. They sold a total of 1,484 shares worth more than $516,727.20. The most recent insider tranaction occured on June, 3rd when Director Timothy C Stonesifer bought 2,790 shares worth more than $400,392.90. Insiders at Insulet own 0.4% of the company. Learn More about insider trades at Insulet.
Information on this page was last updated on 6/3/2026.

Timothy C. Stonesifer Insider Trading History at Insulet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/3/2026	Buy	2,790	$143.51	$400,392.90	9,041

Timothy C. Stonesifer Buying and Selling Activity at Insulet

Insulet Company Overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Today's Range

Now: $153.07

$149.21

$154.49

50 Day Range

MA: $176.99

$142.43

$218.11

2 Week Range

Now: $153.07

$140.63

$354.88

Volume

458,186 shs

Average Volume

1,173,607 shs

Market Capitalization

$10.60 billion

P/E Ratio

35.56

Dividend Yield

N/A

Beta

1.13